Legislative Options and Opportunities

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.24, Iss.3, 1996-12, pp. : 240-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Guide to ASCP's Legislative and Regulatory “Partners”

By Soukup Bryan J.

The Consultant Pharmacist, Vol. 29, Iss. 6, 2014-06 ,pp. : 424-424

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Part II: The Legislative Environment of Pharmaceutical Marketing

By Smith Mickey C.

Journal of Pharmaceutical Marketing & Management, Vol. 18, Iss. 1, 2008-01 ,pp. : 17-89

Haworth Press

Access to resources Recommend Favorite

Bioequivalence: Issues and Options

By Midha Kamal K. Rawson Maureen J. Hubbard John W.

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 743-752

Springer Publishing Company

Access to resources Recommend Favorite

Kleptomania: Diagnosis and Treatment Options

By Durst R.

CNS Drugs, Vol. 15, Iss. 3, 2001-01 ,pp. : 185-195

Adis International

Access to resources Recommend Favorite

Cost effective treatment options for AS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite